Impact of Chondroitin Sulfate Proteoglycan 4 Pseudogene 12 Genetic Variants on Colorectal Cancer Risk: A Case-Control Study
DNA and Cell Biology · 2024
DOI: 10.1089/dna.2024.0174 ↗Kurz gefasst
Fall-Kontroll-Studie in der Zeitschrift DNA and Cell Biology, 2024. Verfasst von Xianlei Zhou und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Public Health, North China University of Science and Technology, Tangshan, China. Hauptthemen laut MEDLINE: Colorectal Neoplasms, Polymorphism, Single Nucleotide, Genetic Predisposition to Disease. Die Arbeit nennt 30 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Public Health, North China University of Science and Technology, Tangshan, China.
- Hebei Key Laboratory of Occupational Health and Safety for Coal Industry, Tangshan, China.
- College of Life Sciences, North China University of Science and Technology, Tangshan, China.
- Affiliated Tangshan Gongren Hospital, North China University of Science and Technology, Tangshan, China.
ORCID-Profile: Xuemei Zhang
Zitieren
APA
Zhou, X., Guo, L., Yang, Z., Xu, H., Zhang, Z., & Zhang, X. (2024). Impact of Chondroitin Sulfate Proteoglycan 4 Pseudogene 12 Genetic Variants on Colorectal Cancer Risk: A Case-Control Study. DNA and Cell Biology. https://doi.org/10.1089/dna.2024.0174
Vancouver
Zhou X, Guo L, Yang Z, Xu H, Zhang Z, Zhang X. Impact of Chondroitin Sulfate Proteoglycan 4 Pseudogene 12 Genetic Variants on Colorectal Cancer Risk: A Case-Control Study. DNA and Cell Biology. 2024. doi:10.1089/dna.2024.0174
BibTeX
@article{Zhou2024,
author = {Zhou, Xianlei and Guo, Liwen and Yang, Zhenbang and Xu, Hongxue and Zhang, Zhi and Zhang, Xuemei},
title = {Impact of Chondroitin Sulfate Proteoglycan 4 Pseudogene 12 Genetic Variants on Colorectal Cancer Risk: A Case-Control Study},
journal = {DNA and Cell Biology},
year = {2024},
doi = {10.1089/dna.2024.0174}
}
EUVIMED